コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 stroke, heart failure, revascularization, or sudden cardiac arrest).
2 portant opportunity to improve survival from sudden cardiac arrest.
3 45 patients, 79%) or secondary prevention of sudden cardiac arrest.
4 lar fibrillation as the presenting rhythm in sudden cardiac arrest.
5 cantly decreased as the presenting rhythm in sudden cardiac arrest.
6 tion remains as the leading causal rhythm of sudden cardiac arrest.
7 rstood how adenoviral infection may underlie sudden cardiac arrest.
8 f ventricular arrhythmias, which can lead to sudden cardiac arrest.
9 re defined as a composite of SCD and aborted sudden cardiac arrest.
10 chemia (cardiac arrest) differs from that of sudden cardiac arrest.
11 D implantation for the primary prevention of sudden cardiac arrest.
12 een associated with increased survival after sudden cardiac arrest.
13 substantial portion of patients experiencing sudden cardiac arrest.
14 ion is a lifesaving technique for victims of sudden cardiac arrest.
15 icular fibrillation (IVF) is a rare cause of sudden cardiac arrest.
16 nce the objectives of improving outcomes for sudden cardiac arrest.
17 e (LQTS) may result in syncope, seizures, or sudden cardiac arrest.
18 ons and secondary prevention in survivors of sudden cardiac arrest.
19 vel cause of J-wave syndrome associated with sudden cardiac arrest.
20 nt low survival rate of youth who experience sudden cardiac arrest.
21 with increased propensity for arrhythmia and sudden cardiac arrest.
22 s to protect youth and improve survival from sudden cardiac arrest.
23 th prolonged QT intervals, tachycardias, and sudden cardiac arrest.
24 ated with mild therapeutic hypothermia after sudden cardiac arrest.
25 lood cell membranes has been associated with sudden cardiac arrest.
26 arrest in 1 (3 died), representing 24.5% of sudden cardiac arrests.
28 significant arrhythmias were defined as: 1) sudden cardiac arrest; 2) nonsustained and sustained ven
29 s (15.6%) experienced the primary outcome (9 sudden cardiac arrest, 40 appropriate implantable cardio
31 defibrillator for the primary prevention of sudden cardiac arrest after baseline clinical evaluation
32 mendations designed to improve survival from sudden cardiac arrest and acute life-threatening cardiop
33 treated with thrombolysis, or had suffered a sudden cardiac arrest and could be treated with cardiopu
37 ing best practices for prevention of primary sudden cardiac arrest and death, including preparticipat
39 ic marker, for example, for prostate cancer, sudden cardiac arrest and neurodegenerative disorders.
40 enced the composite end point (including one sudden cardiac arrest and one sudden death in the nonvig
44 40% survive to hospitalization (resuscitated sudden cardiac arrest), and 9% to 16% survive to hospita
45 vents at 5-year follow-up: SCD, resuscitated sudden cardiac arrest, and aborted SCD, that is, appropr
46 pitalization for angina, resuscitation after sudden cardiac arrest, and coronary revascularization.
48 rrences of sustained ventricular arrhythmia, sudden cardiac arrest, appropriate defibrillator shock,
49 During 4.1 years of follow-up, there were 33 sudden cardiac arrests (arrhythmic death or implantable
50 osite end point included death, resuscitated sudden cardiac arrest, arrhythmic syncope, and appropria
51 piratory symptoms that quickly progressed to sudden cardiac arrest as a consequence of late-onset dia
52 nts with Brugada Syndrome with high risk for sudden cardiac arrest, asymptomatic or intermediate-risk
53 tle is known about the relative frequency of sudden cardiac arrest at traditional indoor exercise fac
54 ion, a cohort greatly contributing to global sudden cardiac arrest burden, this marker provides robus
57 ing lay responders to recognize the signs of sudden cardiac arrest, call 9-1-1, and perform CPR in pu
59 th a continuing decline in the prevalence of sudden cardiac arrest cases presenting with ventricular
61 s is associated with improved survival after sudden cardiac arrest, contrary to PCI of stable lesions
63 st [VFRisk]) for the prediction of shockable sudden cardiac arrest, discovered and validated in 2 US
64 red benign until 2008, when it was linked to sudden cardiac arrest due to idiopathic ventricular fibr
67 of-hospital cardiac arrest, the incidence of sudden cardiac arrest during participation in competitiv
70 ation screening programs aimed at preventing sudden cardiac arrest during sports activities are thoug
71 of adverse cardiovascular events, including sudden cardiac arrest, during competitive sports partici
73 therapeutic, and resuscitative support after sudden cardiac arrest from many different cardiac causes
77 s) are extensively deployed to rapidly treat sudden cardiac arrest in adults, their applicability for
79 Our purpose was to review recent data on sudden cardiac arrest in children and its outcome to ide
80 verter defibrillators (ICDs) used to prevent sudden cardiac arrest in children not only provide appro
84 CMR identified a likely pathogenesis for sudden cardiac arrest in nearly half of survivors in who
85 arrhythmogenic cardiomyopathies can lead to sudden cardiac arrest in otherwise healthy individuals.
86 14 from a prospective registry enrolling all sudden cardiac arrest in Paris and suburbs (6.7 million
87 coding genes seem to be an uncommon cause of sudden cardiac arrest in patients with apparent J-wave s
91 Ds) among subjects who eventually experience sudden cardiac arrest in the general population have not
92 e sudden death in the nonvigorous group, one sudden cardiac arrest in the vigorous group) with overal
93 he relative frequency, care, and survival of sudden cardiac arrest in traditional indoor exercise fac
97 following cardiopulmonary resuscitation for sudden cardiac arrest is common, occurring even in the a
101 The most common location of out-of-hospital sudden cardiac arrest is the home, a situation in which
104 o moderate hypothermia is neuroprotective in sudden cardiac arrest, ischemic stroke, perinatal hypoxi
105 cases (2003-2012), 448 had appropriate pre- sudden cardiac arrest left ventricular ejection fraction
106 nal analysis within the ESCAPE-NET (European Sudden Cardiac Arrest network: Towards Prevention, Educa
107 e in arrhythmias, despite the fact that most sudden cardiac arrest occur in the setting of ischemia.
110 18.5 million person-years of observation, 74 sudden cardiac arrests occurred during participation in
111 brillator to receive one of two responses to sudden cardiac arrest occurring at home: either the cont
114 of fibrosis was an independent predictor of sudden cardiac arrest or appropriate implantable cardiac
115 is is the strongest independent predictor of sudden cardiac arrest or appropriate implantable cardiac
116 ere followed up for the primary end point of sudden cardiac arrest or appropriate implantable cardiac
117 nce were followed for the primary outcome of sudden cardiac arrest or appropriate implantable cardiov
122 den" OR the terms "sudden cardiac death" OR "sudden cardiac arrest" OR "cardiac arrest" OR "cardiac d
123 ntricular assist device, resuscitation after sudden cardiac arrest, or appropriate lifesaving shock),
124 ndividuals to arrhythmic syncope or seizure, sudden cardiac arrest, or sudden cardiac death (SCD).
125 ioverter defibrillator intervention, aborted sudden cardiac arrest, or sudden cardiac death) correspo
126 r in the United States, >350 000 people have sudden cardiac arrest outside of a hospital environment.
127 ulation in approximately 50% of normovolemic sudden cardiac arrests outside hospitals and in essentia
128 rcutaneous coronary intervention (PCI) after sudden cardiac arrest, particularly in the absence of ST
129 t to evaluate the role of CMR in determining sudden cardiac arrest pathogenesis and prognosis in surv
130 Epinephrine is routinely administered to sudden cardiac arrest patients during resuscitation, but
133 inherited disease (CID) causing resuscitated sudden cardiac arrest (RSCA) on a population basis is un
135 ements in management following survival from sudden cardiac arrest (SCA) and wide availability of imp
136 urrent data describing the true incidence of sudden cardiac arrest (SCA) and/or sudden cardiac death
138 eople with epilepsy are at increased risk of sudden cardiac arrest (SCA) due to ECG-confirmed ventric
139 ate the risk in this population by assessing sudden cardiac arrest (SCA) due to ventricular tachycard
140 ctiveness of emergency response planning for sudden cardiac arrest (SCA) in a large cohort of US high
141 High-resolution stratification of risk of sudden cardiac arrest (SCA) in individual patients is a
149 P), a highly heritable condition, experience sudden cardiac arrest (SCA) or sudden cardiac death (SCD
150 ut not serious arrhythmogenic endpoints like sudden cardiac arrest (SCA) or ventricular arrhythmia (V
152 In contrast, prehospital mortality from sudden cardiac arrest (SCA) remains high and difficult t
154 he 21st century, the fact that survival from sudden cardiac arrest (SCA) remains lower than 10% in mo
156 could affect coronary heart disease (CHD) or sudden cardiac arrest (SCA) via generation of specific f
157 mplantable cardioverter-defibrillator shock, sudden cardiac arrest (SCA), and sudden cardiac death.
158 defined as sustained ventricular arrhythmia, sudden cardiac arrest (SCA), or ventricular tachycardia
169 ly 56% had an arrhythmic cause; resuscitated sudden cardiac arrests (SCAs) were excluded because they
176 congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coro
177 and 9% to 16% survive to hospital discharge (sudden cardiac arrest survivor), of whom approximately 9
179 illator implant is indicated for young adult sudden cardiac arrest survivors with nonreversible cardi
183 (SCD) was highlighted during the most recent Sudden Cardiac Arrest Thought Leadership Alliance's (SCA
184 s improve the survival of youth experiencing sudden cardiac arrest to 74% when optimal programs are i
186 ted the composite end point of sudden death, sudden cardiac arrest, ventricular arrhythmia treated by
187 k score (risk prediction score for shockable sudden cardiac arrest [VFRisk]) for the prediction of sh
190 tachycardia [VT] or fibrillation, [aborted] sudden cardiac arrest) was assessed in all patients.
191 imately 1 million), cases of out-of-hospital sudden cardiac arrest who underwent attempted resuscitat